Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$216M |
| 2 |
Apple
AAPL
|
+$215M |
| 3 |
KeyCorp
KEY
|
+$212M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$210M |
| 5 |
Synchrony
SYF
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.82B |
| 2 |
Comcast
CMCSA
|
+$427M |
| 3 |
Amazon
AMZN
|
+$418M |
| 4 |
SLB Ltd
SLB
|
+$312M |
| 5 |
Ameren
AEE
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.36% |
| 2 | Energy | 10.86% |
| 3 | Financials | 9.53% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Technology | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
PUT
Vertex Pharmaceuticals
VRTX
$139B
| $18.9M | 0.04% |
150,000
| – | – |
|
602
Clorox
CLX
$12.9B
| $18.7M | 0.04% |
147,203
+2,331
| +2% | +$289K |
|
603
LendingTree
TREE
$433M
| $18.6M | 0.04% |
208,686
+165,898
| +388% | +$17.1M |
|
604
CALL
Fluor
FLR
$7.01B
| $18.6M | 0.04% |
394,200
| – | – |
|
|
UFS
605
DELISTED
DOMTAR CORPORATION (New)
UFS
| $18.6M | 0.04% |
503,619
+495,956
| +6,472% | +$19.6M |
|
606
EQT Corp
EQT
$33.6B
| $18.6M | 0.04% |
653,961
-5,908,821
| -90% | -$198M |
|
607
Nektar Therapeutics
NKTR
$2.53B
| $18.5M | 0.04% |
73,324
-195,677
| -73% | -$40.2M |
|
608
Asbury Automotive
ABG
$3.86B
| $18.4M | 0.04% |
272,790
+269,490
| +8,166% | +$20.5M |
|
609
New Oriental
EDU
$8.88B
| $18.3M | 0.04% |
584,172
+324,253
| +125% | +$9.13M |
|
610
Deere & Co
DE
$175B
| $18.3M | 0.04% |
239,689
+181,489
| +312% | +$14M |
|
|
RDS.A
611
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $18.2M | 0.04% |
420,254
-322,040
| -43% | -$15.3M |
|
612
Steris
STE
$23.2B
| $18.2M | 0.04% |
242,087
+131,808
| +120% | +$9.52M |
|
613
CALL
Gilead Sciences
GILD
$181B
| $18.2M | 0.04% |
+180,000
| New | +$18.7M |
|
|
PPS
614
DELISTED
Post Properties
PPS
| $18.2M | 0.04% |
307,681
+184,728
| +150% | +$10.9M |
|
|
CHSP
615
DELISTED
Chesapeake Lodging Trust
CHSP
| $18.2M | 0.04% |
722,011
+374,529
| +108% | +$10.2M |
|
|
TXNM
616
TXNM Energy Inc
TXNM
$5.9B
| $18.1M | 0.04% |
591,678
-1,360,459
| -70% | -$39M |
|
617
Carlisle Companies
CSL
$14.6B
| $18.1M | 0.04% |
+203,808
| New | +$18M |
|
618
iShares Silver Trust
SLV
$33.8B
| $18M | 0.04% |
1,366,102
-168,819
| -11% | -$2.38M |
|
619
Universal Insurance Holdings
UVE
$1.18B
| $18M | 0.04% |
775,271
+674,962
| +673% | +$18.6M |
|
620
Accuray
ARAY
$33.6M
| $17.9M | 0.04% |
2,649,977
+1,641,481
| +163% | +$10.5M |
|
621
IBM
IBM
$222B
| $17.9M | 0.04% |
+135,800
| New | +$18.2M |
|
622
Xylem
XYL
$26.5B
| $17.8M | 0.04% |
487,601
-2,112,493
| -81% | -$76.4M |
|
623
Red Robin
RRGB
$189M
| $17.8M | 0.04% |
287,931
-87,861
| -23% | -$6.16M |
|
|
CPN
624
DELISTED
Calpine Corporation
CPN
| $17.8M | 0.04% |
1,228,286
-212,679
| -15% | -$3.11M |
|
625
Humana
HUM
$45.5B
| $17.7M | 0.04% |
99,233
+91,214
| +1,137% | +$16M |
|
Similar funds
Israel Englander's Q4 2015 Portfolio in Review
As of Q4 2015, Israel Englander held 4,144 positions worth $47.6B, down 7.9% from $51.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Israel Englander withdrew a net $5.89B in Q4 2015, closing 778 positions and reducing 1,349 holdings. Its most notable exit was Illumina, an estimated $86.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Energy and Financials.
Against the trend, Israel Englander opened a new position in Alphabet (Google) Class A worth $221M.
- Israel Englander's largest Q4 2015 buy was Alphabet (Google) Class A: 5,673,120 shares worth $221M.
- Israel Englander added most to Merck in Q4 2015, an estimated $216M increase.
- Israel Englander's biggest Q4 2015 reduction was DuPont de Nemours, cutting an estimated $1.82B.
- Israel Englander fully exited Illumina in Q4 2015, selling an estimated $86.9M.
- Israel Englander's ten largest holdings make up 10% of its $47.6B portfolio in Q4 2015.
- Israel Englander opened 733 new positions and closed 778 in Q4 2015.
- Israel Englander's portfolio value fell 7.9% quarter-over-quarter to $47.6B.
Based on Millennium Management's 13F filing for Q4 2015, filed 16 Feb 2016.